A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Experts express enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades.

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...